Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  neutropenia
Country:  U.S.A.
Trial Type:  Supportive care
Results 1-7 of 7 for your search:
Start Over
RAnDomized Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Breast CANCEr Patients Receiving Docetaxel and Cyclophosphamide
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: SPI-GCF-301, NCI-2016-00155, NCT02643420
Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 to 75
Trial IDs: SOL-04058-L, NCI-2013-00786, 2868, CR00002456, OHSU-8507, OHSU-2868, OHSU-SOL-04058-L, NCT00303849
Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia
Phase: Phase II
Type: Supportive care
Age: 55 and over
Trial IDs: CLT008-03, NCI-2014-02461, NCT02282215
Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Age: 2 to 17
Trial IDs: 5592-097, NCI-2015-01381, 2014-002807-10, MK-5592-097, NCT02452034
Neutropenic Diet in Preventing Infections in Younger Patients Receiving Chemotherapy
Phase: No phase specified
Type: Supportive care
Age: 1 to 21
Trial IDs: 06-08-367, NCI-2014-01519, NCI-2014-01460, NCT00726934
Modified Donor Stem Cells in Preventing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Phase: No phase specified
Type: Supportive care
Age: 21 and under
Trial IDs: 10082, NCI-2011-03241, NCT01200017
Start Over